PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.43%
Revenue growth 1.25-1.5x Insurance - Life median of 4.12%. Mohnish Pabrai would see if this gap is sustainable or cyclical.
5.43%
Gross profit growth 1.25-1.5x Insurance - Life median of 4.12%. Mohnish Pabrai would see if economies of scale justify the premium growth.
48.13%
EBIT growth exceeding 1.5x Insurance - Life median of 6.16%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
48.13%
Operating income growth exceeding 1.5x Insurance - Life median of 15.91%. Joel Greenblatt would see if unique processes drive exceptional profitability.
45.25%
Net income growth exceeding 1.5x Insurance - Life median of 3.92%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
45.22%
EPS growth exceeding 1.5x Insurance - Life median of 1.09%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
45.26%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 1.09%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.28%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-24.28%
Negative FCF growth while Insurance - Life median is -3.57%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
48.59%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 26.12%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
-45.85%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
84.44%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 10.56%. Joel Greenblatt might see a short-term competitive advantage at play.
1439.77%
OCF/share CAGR of 1439.77% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
-38.57%
Negative 5Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-28.85%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
222.31%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 32.67% over a decade. Joel Greenblatt might see a standout compounder of earnings.
171.93%
5Y net income/share CAGR > 1.5x Insurance - Life median of 47.51%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
-25.03%
Negative 3Y CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
209.54%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 9.68% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
4.61%
Below 50% of Insurance - Life median. Jim Chanos suspects weak profitability or questionable capital allocation limiting equity growth.
7.27%
3Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier suspects suboptimal short-term capital usage vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.01%
AR growth of 5.01% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
3.09%
Asset growth exceeding 1.5x Insurance - Life median of 1.20%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
8.01%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-0.44%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
16.96%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.